Skip to content

About Us
Our Technology
Clinical
Leadership Team
- Board
- Management Team
Investor Centre
Recruitment
Contact Us

About Us
Our Technology
Clinical
Leadership Team
- Board
- Management Team
Investor Centre
Recruitment
Contact Us

cancer-fighting-biotech-immvirx-secures--15m-from-oneventures

News
June 6, 2023

Cancer-fighting biotech ImmVirX secures $15m from OneVentures

You can read the full story here.

Join Our Mailing List

Our mission is to develop receptor-targeted oncolytic RNA immunotherapies that improve outcomes for patients with cancers that are difficult to treat

A clinical-stage company developing receptor-targeted oncolytic RNA immunotherapies for cancers with high unmet need.

Twitter Linkedin

Company

About Us
Our Technology
Clinical
Leadership Team
- Board
- Management Team
Investor Centre
Recruitment
Contact Us

About Us
Our Technology
Clinical
Leadership Team
- Board
- Management Team
Investor Centre
Recruitment
Contact Us

© 2026 ImmVirX Pty Ltd • Website developed by Noise